Search results
Results From The WOW.Com Content Network
Raiden Shogun (Chinese: 雷电将军; pinyin: Léidiàn Jiāngjūn) is a character from Genshin Impact, a 2020 action role-playing gacha game developed by miHoYo.Added in a 2021 update for the game, she was initially a boss enemy for players to fight, and then later released as a playable character.
After barely escaping the Shogun's forces, the Traveler and Paimon join a band of separatists on Inazuma's Watatsumi Island before meeting Scaramouche, the Sixth Fatui Harbinger. Though he knocks the Traveler and Paimon unconscious, Yae Miko – the Shogun's familiar – grants him Raiden's Gnosis in exchange for their lives. After recovering ...
The Eighth Fatui Harbinger, she steals Venti's Gnosis, bargains with Zhongli for his Gnosis, and tries taking the Raiden Shogun's Gnosis as the Tsaritsa desires to collect all Archons' Gnoses. After helping to incite turmoil and a civil war in the nation of Inazuma, the Traveler challenges her to a duel that leads to her execution by the Raiden ...
Raiden Shogun; Y. Yun Jin; Z. Zhongli (Genshin Impact) This page was last edited on 31 December 2024, at 06:00 (UTC). Text is available under the Creative ...
The drugs would have been worth up to NZ$3.8 million, or $2.2 million USD, the customs agency said in a news release. The duffel bag and disguised drugs. / Credit: New Zealand Customs Service.
To me, Raiden is more inclusive than Raiden Shogun, but neither perfectly covers the broad range of titles the game and the media use to refer to her. In my opinion, Raiden Shogun being the overwhelmingly more popular name outweighs the slight benefit of having a more inclusive name. PetraMagna 22:49, 20 July 2023 (UTC)
“Shogun” is moving closer to a new season. Hot off its awards dominance at the 2025 Golden Globes — winning the drama series prize, as well as three acting wins — the writers behind ...
Two high-yield stocks worth buying. For income investors, these pharmaceutical giants offer two distinct paths forward. Bristol-Myers Squibb provides a higher 4.3% yield and an acquisition-driven ...